Product Description:

• CIMZIA® (certolizumab pegol) is a medication used to treat adults with plaque psoriasis (PsO).
• The active ingredient of CIMZIA® is called certolizumab pegol, a humanized antibody.
• Antibodies are proteins that identify other proteins and bind to them.
• People with PsO usually have too much of a protein called tumour necrosis factor alpha (TNFα) in their bodies, which can cause symptoms of PsO. CIMZIA® works by binding itself to TNFα in order to reduce the amount of TNFα in the body back to normal levels, thus alleviating the inflammation.
• CIMZIA® helps reduce the signs and symptoms of psoriasis, such as pain, itching and scaly patches on the skin

How to use:

• CIMZIA® is given by an injection under the skin (called a subcutaneous injection).
• When you are first prescribed CIMZIA®, your physician will instruct you to take 400 mg of CIMZIA® at weeks 0, 2, and 4

Caution & Warnings:

• If you forget to take your dose of CIMZIA® at your regularly scheduled time,
• do as follows:
• If your next scheduled dose is within 1 week, wait until your next scheduled dose
• If your next scheduled dose is 1 week or longer, inject the missed dose as soon
• as you become aware of it, and then follow with your next scheduled dose
• Please speak to your Dermatologist about CIMZIA® use when family planning, during pregnancy or if you are breastfeeding. CIMZIA® should be used during pregnancy only if clearly needed. The use of CIMZIA® may be considered during breastfeeding

Side Effects:

• Upper respiratory tract infections (such as flu, cold)
• Other infections including pneumonia,
• ponchopneumonia (a ponchitis) and
• herpes zoster (shingles)
• Fatigue
• Skin infections

Ingredients:

• certolizumab pegol